Millipore Sigma Vibrant Logo

MAB011-A/13 Anti-Apolipoprotein A-I Antibody, clone A/13

View This Product on Sigma-Aldrich
MAB011-A/13
250 µg  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited Availability
Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Special Offers

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Spec Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      HELISA, RIAMPurifiedMonoclonal Antibody
      Description
      Catalogue NumberMAB011-A/13
      Brand Family Chemicon®
      Trade Name
      • Chemicon
      DescriptionAnti-Apolipoprotein A-I Antibody, clone A/13
      Alternate Names
      • ApoAI
      References
      Product Information
      FormatPurified
      PresentationIgG fraction purified from mouse ascites by DEAE column chromatography. In 0.015 M potassium phosphate buffer with 0.15M NaCl, 0.1% sodium azide, pH 7.2.
      Quality LevelMQ100
      Applications
      ApplicationAnti-Apolipoprotein A-I Antibody, clone A/13 detects level of Apolipoprotein A-I & has been published & validated for use in ELISA, RIA.
      Key Applications
      • ELISA
      • Radioimmunoassay
      Application NotesCompetitive RIA or EIA

      Optimal working dilutions must be determined by the end user.
      Biological Information
      ImmunogenPurified human plasma Apo A-I.
      CloneA/13
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      HostMouse
      SpecificityApolipoprotein A-I. No cross reactivity to Apo A-II or Apo B.

      AFFINITY CONSTANT: 8 x 10E9 L/mol
      IsotypeIgG1
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Entrez Gene SummaryThis gene encodes apolipoprotein A-I, which is the major protein component of high density lipoprotein (HDL) in plasma. The protein promotes cholesterol efflux from tissues to the liver for excretion, and it is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. This gene is closely linked with two other apolipoprotein genes on chromosome 11. Defects in this gene are associated with HDL deficiencies, including Tangier disease, and with systemic non-neuropathic amyloidosis.
      Gene Symbol
      • APOA1
      • ApoA-I
      • preproapolipoprotein
      • amyloidosis
      • MGC117399
      • Apo-AI
      UniProt Number
      UniProt SummaryFUNCTION: SwissProt: P02647 # Participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase (LCAT).
      SIZE: 267 amino acids; 30778 Da
      SUBUNIT: Interacts with APOA1BP.
      SUBCELLULAR LOCATION: Secreted.
      TISSUE SPECIFICITY: Major protein of plasma HDL, also found in chylomicrons. Synthesized in the liver and small intestine.
      PTM: Palmitoylated.
      DISEASE: SwissProt: P02647 # Defects in APOA1 are a cause of high density lipoprotein deficiency type 2 (HDLD2) [MIM:604091]; also known as familial hypoalphalipoproteinemia (FHA). Inheritance is autosomal dominant. & Defects in APOA1 are a cause of the low HDL levels observed in high density lipoprotein deficiency type 1 (HDLD1) [MIM:205400]; also known as analphalipoproteinemia or Tangier disease (TGD). HDLD1 is a recessive disorder characterized by the absence of plasma HDL, accumulation of cholesteryl esters, premature coronary artery disease, hepatosplenomegaly, recurrent peripheral neuropathy and progressive muscle wasting and weakness. In HDLD1 patients, ApoA-I fails to associate with HDL probably because of the faulty conversion of pro-ApoA-I molecules into mature chains, either due to a defect in the converting enzyme activity or a specific structural defect in Tangier ApoA-I. & Defects in APOA1 are a cause of systemic non-neuropathic amyloidosis [MIM:105200]; also known as amyloidosis VIII or Ostertag-type amyloidosis. It is an autosomal dominant disorder characterized by generalized amyloid deposition.
      SIMILARITY: SwissProt: P02647 ## Belongs to the apolipoprotein A1/A4/E family.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsMaintain at -20°C in undiluted aliquots for up to 12 months. Do not store below -20°C or in dry ice as precipitation may occur. Avoid repeated freeze/thaw cycles.
      Packaging Information
      Material Size250 µg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      MAB011-A/13 04053252614804

      Related Products & Applications

      Product Families

      Categories

      Life Science Research > Antibodies and Assays > Primary Antibodies